The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on “medical spending and effectiveness that flared during the battle over health-care reform,” The Washington Post reports. “The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer…
Related posts:
The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on “medical spending and effectiveness that flared during the battle over health-care reform,” The Washington Post reports. “The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer…
Related posts:
No Comments on “FDA Considers Dropping Avastin Approval, Approves Five-Day Emergency Contraception Pill”
You can track this conversation through its atom feed.
on
No Comments on “FDA Considers Dropping Avastin Approval, Approves Five-Day Emergency Contraception Pill”
You can track this conversation through its atom feed.